- -

Protein-Functionalized Microgel for Multiple Myeloma Cells' 3D Culture

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Protein-Functionalized Microgel for Multiple Myeloma Cells' 3D Culture

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Marin-Paya, Juan Carlos es_ES
dc.contributor.author Clara-Trujillo, Sandra es_ES
dc.contributor.author Cordón, Lourdes es_ES
dc.contributor.author Gallego-Ferrer, Gloria es_ES
dc.contributor.author Sempere, Amparo es_ES
dc.contributor.author Gómez Ribelles, José Luís es_ES
dc.date.accessioned 2023-04-21T18:01:43Z
dc.date.available 2023-04-21T18:01:43Z
dc.date.issued 2022-11 es_ES
dc.identifier.uri http://hdl.handle.net/10251/192919
dc.description.abstract [EN] Multiple myeloma is a hematologic neoplasm caused by an uncontrolled clonal proliferation of neoplastic plasma cells (nPCs) in the bone marrow. The development and survival of this disease is tightly related to the bone marrow environment. Proliferation and viability of nPCs depend on their interaction with the stromal cells and the extracellular matrix components, which also influences the appearance of drug resistance. Recapitulating these interactions in an in vitro culture requires 3D environments that incorporate the biomolecules of interest. In this work, we studied the proliferation and viability of three multiple myeloma cell lines in a microgel consisting of biostable microspheres with fibronectin (FN) on their surfaces. We also showed that the interaction of the RPMI8226 cell line with FN induced cell arrest in the G0/G1 cell cycle phase. RPMI8226 cells developed a significant resistance to dexamethasone, which was reduced when they were treated with dexamethasone and bortezomib in combination. es_ES
dc.description.sponsorship This research was funded by the Generalitat Valenciana, grant number PROMETEO/2016/063; JLGR acknowledges that support by was funded by the Spanish State Research Agency (AEI) through the PID2019-106099RB-C41/AEI/10.13039/501100011033 project. es_ES
dc.language Inglés es_ES
dc.publisher MDPI AG es_ES
dc.relation.ispartof Biomedicines es_ES
dc.rights Reconocimiento (by) es_ES
dc.subject Multiple myeloma es_ES
dc.subject Microgel es_ES
dc.subject Fibronectin es_ES
dc.subject Dexamethasone es_ES
dc.subject Bortezomib es_ES
dc.subject.classification MAQUINAS Y MOTORES TERMICOS es_ES
dc.title Protein-Functionalized Microgel for Multiple Myeloma Cells' 3D Culture es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.3390/biomedicines10112797 es_ES
dc.relation.projectID info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-106099RB-C41/ES/MICROGELES BIOMIMETICOS PARA EL ESTUDIO DE LA GENERACION DE RESISTENCIAS A FARMACOS EN EL MIELOMA MULTIPLE/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/GVA//PROMETEO%2F2016%2F063//MEDULA OSEA ARTIFICIAL PARA PERSONALIZAR EL TRATAMIENTO DE PACIENTES DE CANCERES DE SANGRE/ es_ES
dc.rights.accessRights Abierto es_ES
dc.contributor.affiliation Universitat Politècnica de València. Escuela Técnica Superior de Ingenieros Industriales - Escola Tècnica Superior d'Enginyers Industrials es_ES
dc.description.bibliographicCitation Marin-Paya, JC.; Clara-Trujillo, S.; Cordón, L.; Gallego-Ferrer, G.; Sempere, A.; Gómez Ribelles, JL. (2022). Protein-Functionalized Microgel for Multiple Myeloma Cells' 3D Culture. Biomedicines. 10(11):1-12. https://doi.org/10.3390/biomedicines10112797 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion https://doi.org/10.3390/biomedicines10112797 es_ES
dc.description.upvformatpinicio 1 es_ES
dc.description.upvformatpfin 12 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 10 es_ES
dc.description.issue 11 es_ES
dc.identifier.eissn 2227-9059 es_ES
dc.identifier.pmid 36359316 es_ES
dc.identifier.pmcid PMC9687145 es_ES
dc.relation.pasarela S\483858 es_ES
dc.contributor.funder Generalitat Valenciana es_ES
dc.contributor.funder Instituto de Salud Carlos III es_ES
dc.contributor.funder AGENCIA ESTATAL DE INVESTIGACION es_ES
dc.contributor.funder European Regional Development Fund es_ES
dc.contributor.funder Ministerio de Ciencia e Innovación es_ES
dc.contributor.funder Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina es_ES
dc.subject.ods 03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edades es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem